Cancer Incidence for the City of Buffalo, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 1,440.6 | 515.2 | 503.0-527.7 | 716.8 | 567.6 | 548.4-587.3 | 723.8 | 480.6 | 464.5-497.2 |
| Oral cavity and pharynx | 39.0 | 13.2 | 11.4-15.3 | 26.6 | 19.5 | 16.2-23.3 | 12.4 | 8.0 | 6.1-10.3 |
| Esophagus | 15.0 | 5.2 | 4.1-6.6 | 10.4 | 7.8 | 5.8-10.4 | 4.6 | 3.0 | 1.9-4.6 |
| Stomach | 26.6 | 10.2 | 8.5-12.2 | 15.2 | 12.9 | 10.0-16.3 | 11.4 | 7.8 | 5.9-10.2 |
| Colorectal | 110.4 | 41.0 | 37.6-44.7 | 54.2 | 44.4 | 39.1-50.3 | 56.2 | 38.0 | 33.6-42.9 |
| Colon excluding rectum | 78.8 | 29.5 | 26.6-32.7 | 36.8 | 30.5 | 26.1-35.5 | 42.0 | 28.5 | 24.6-32.7 |
| Rectum & rectosigmoid | 31.6 | 11.5 | 9.7-13.5 | 17.4 | 13.9 | 11.0-17.3 | 14.2 | 9.6 | 7.4-12.2 |
| Liver / intrahepatic bile duct | 39.0 | 12.5 | 10.8-14.5 | 28.0 | 19.7 | 16.5-23.4 | 11.0 | 6.7 | 5.0-8.9 |
| Pancreas | 44.6 | 16.0 | 13.9-18.4 | 21.6 | 17.4 | 14.1-21.1 | 23.0 | 14.6 | 12.0-17.6 |
| Larynx | 13.6 | 4.7 | 3.6-6.0 | 9.2 | 6.9 | 5.0-9.3 | 4.4 | 3.0 | 1.8-4.6 |
| Lung and bronchus | 226.4 | 78.9 | 74.3-83.8 | 107.8 | 87.6 | 80.0-95.6 | 118.6 | 73.7 | 67.7-80.0 |
| Melanoma of the skin | 40.6 | 14.4 | 12.4-16.6 | 20.6 | 16.1 | 13.0-19.7 | 20.0 | 13.6 | 10.9-16.7 |
| Female breast | 184.4 | 126.0 | 117.7-134.8 | ||||||
| Cervix uteri | 11.4 | 8.8 | 6.5-11.5 | ||||||
| Corpus uterus and NOS | 48.4 | 31.6 | 27.6-36.1 | ||||||
| Ovary | 17.4 | 11.6 | 9.2-14.4 | ||||||
| Prostate | 195.4 | 145.3 | 136.0-155.1 | ||||||
| Testis | 7.6 | 5.8 | 4.0-8.1 | ||||||
| Urinary bladder (incl. in situ) | 61.0 | 21.8 | 19.4-24.5 | 40.6 | 33.9 | 29.2-39.1 | 20.4 | 12.8 | 10.4-15.7 |
| Kidney and renal pelvis | 51.8 | 18.6 | 16.4-21.1 | 30.0 | 24.5 | 20.6-28.9 | 21.8 | 14.2 | 11.6-17.3 |
| Brain and other central nervous system | 15.6 | 5.7 | 4.4-7.1 | 8.2 | 6.3 | 4.4-8.6 | 7.4 | 5.1 | 3.6-7.2 |
| Thyroid | 28.4 | 11.5 | 9.6-13.6 | 7.8 | 6.5 | 4.5-9.0 | 20.6 | 16.2 | 13.1-19.8 |
| Hodgkin lymphoma | 6.6 | 2.3 | 1.6-3.4 | 4.2 | 3.4 | 2.0-5.2 | 2.4 | 1.4 | 0.7-2.6 |
| Non-Hodgkin lymphomas | 52.4 | 19.6 | 17.2-22.2 | 26.8 | 23.0 | 19.1-27.4 | 25.6 | 17.1 | 14.2-20.5 |
| Myeloma | 28.4 | 10.3 | 8.6-12.2 | 13.0 | 11.4 | 8.7-14.7 | 15.4 | 9.8 | 7.7-12.4 |
| Leukemias | 45.8 | 16.9 | 14.7-19.3 | 28.8 | 24.4 | 20.4-28.9 | 17.0 | 11.4 | 9.0-14.2 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
